Science Explorer Back to mapMap
Discussion
Researcher · Pharmacyclics (United States) · United States

Betty Y Chang

Betty Y Chang publishes mostly in Genetics, Molecular Biology and Pathology and Forensic Medicine, on topics such as Chronic Lymphocytic Leukemia Research, Lymphoma Diagnosis and Treatment and Monoclonal and Polyclonal Antibodies Research.

ORCID 0009-0000-6363-2484 OpenAlex
World rank
#79,334
of 7,710,434 ranked researchers
Rank in United States
#30,596
of 1,627,098
Works
190
Citations
21k
Citations per work
112.5
h-index
47
i10-index 64Top 4.9% in Genetics (Medicine)
Betty Y Chang

What does Betty Y Chang research?

Betty Y Chang's work is mostly in Medicine (47%), Biochemistry, Genetics and Molecular Biology (18%), Immunology and Microbiology (12%).

Health Sciences: 89 works · 46.9% of their workMedicine: 89 works · 46.9% of their workGenetics: 40 works · 21.2% of their workPathology and Forensic Medicine: 23 works · 11.9% of their workOncology: 15 works · 7.8% of their workRadiology, Nuclear Medicine and Imaging: 11 works · 6.0% of their workLife Sciences: 56 works · 29.5% of their workBiochemistry, Genetics and Molecular Biology: 34 works · 17.9% of their workMolecular Biology: 34 works · 17.9% of their workImmunology and Microbiology: 22 works · 11.6% of their workImmunology: 22 works · 11.6% of their workEverything else: 45 works · 23.6% of their workTHEIR WORKBetty Y Chang190works
Life Sciences30%Health Sciences47%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine8946.9%
    1. Biochemistry, Genetics and Molecular Biology3417.9%
    2. Immunology and Microbiology2211.6%
  3. Everything else4523.6%
  1. 1Genetics21% of their works
  2. 2Molecular Biology18% of their works
  3. 3Pathology and Forensic Medicine12% of their works
  4. 4Immunology12% of their works
  5. 5Oncology8% of their works
  6. 6Radiology, Nuclear Medicine and Imaging6% of their works

Research topics

Which keywords describe Betty Y Chang's research?

The keywords of their largest research topics: Rituximab, Chronic Lymphocytic Leukemia, Genomic Aberrations, Lymphoma, Classification, Molecular Profiling, Fc Receptors and Therapeutic Antibodies.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 19 words, with their numbers
  1. Rituximab1032 topics
  2. Chronic Lymphocytic Leukemia671 topic
  3. Genomic Aberrations671 topic
  4. Lymphoma432 topics
  5. Classification361 topic
  6. Molecular Profiling361 topic
  7. Fc Receptors191 topic
  8. Therapeutic Antibodies191 topic
  9. Cancer Immunotherapy162 topics
  10. Genetic Mutations141 topic
  11. Primary Immunodeficiency141 topic
  12. BCR-ABL91 topic
  13. CD4791 topic
  14. Imatinib91 topic
  15. apoptotic cells91 topic
  16. CAR T Cells71 topic
  17. Chimeric Antigen Receptor71 topic
  18. Signaling71 topic
  19. mTOR71 topic

Where does Betty Y Chang work?

Betty Y Chang's main affiliation in the publication record is Pharmacyclics (United States), United States.

How many publications and citations does Betty Y Chang have?

OpenAlex counts 190 works and 21,380 citations for Betty Y Chang, an h-index of 47, ranking #79,334 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Betty Y Chang. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.